Finance

Lists
BIOV:CNSX
Biovaxys Technology Corp
CAD 0,070
0,00%
(0,00) 1D
5 Mei, 15:55:53 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOV...
Mkt. cap
3,09 m
Avg. vol.
0,00
Volume
0,00
52-wk high
CAD 0,29
52-wk low
CAD 0,03
Mkt. cap
3,09 m
Avg. vol.
0,00
Volume
0,00
52-wk high
CAD 0,29
52-wk low
CAD 0,03
News stories
From web sources and news partners
About Biovaxys Technology Corp
CEO-
Employees-
Founded-
HeadquartersToronto, Ontario, Kanada
SectorPharmaceutical industry
Websitebiovaxys.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Okt. 2024
Jan. 2025
Apr. 2025
Jul. 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,50 k
32,95 k
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,20 m
1,03 m
1,08 m
859,08 k
Operating expense
1,49 m
1,14 m
1,22 m
859,08 k
Total operating expenses
1,49 m
1,14 m
1,22 m
859,08 k
Operating income
-1,49 m
-1,14 m
-1,22 m
-859,08 k
Other non operating income
-8,90 k
-68,18 k
-67,98 k
-50,97 k
EBT including unusual items
-2,74 m
-1,07 m
-1,32 m
-910,06 k
EBT excluding unusual items
-1,50 m
-1,25 m
-1,30 m
-910,06 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,74 m
-1,07 m
-1,32 m
-910,06 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme